Skip to main content

Century Therapeutics, Inc.

IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850119

In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Century Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of IPSC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders52256+6
Shares22.2M13.3K21.8M−381.3K (−1.7%)
Value$278.9M$168.0K$182.8M−$95.9M (−34.4%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Century Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to IPSC in Q2 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC60,567$509.0K0.00%
Parametrica Management Ltd28,855$241.0K0.26%
Susquehanna International Group, LLP14,152$119.0K0.00%
Delphia (USA) Inc.10,548$89.0K0.06%
Russell Investments Group, Ltd.3,308$27.0K0.00%
National Bank of Canada2,500$21.0K0.00%
Point72 Hong Kong Ltd186$2.00K0.00%
Credit Suisse AG19$00.00%
Captrust Financial Advisors19$00.00%

Sold out (3)

Institutions that held Century Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of IPSC in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
D. E. Shaw & Co., Inc.22,437$282.0K
Allspring Global Investments Holdings, LLC13,908$175.0K
UBS Group AG32$0

Not filed for Q2 2022 yet (2)

Institutions that held Century Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IPSC in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC11,589$146.0K
Amalgamated Financial Corp.1,720$22.0K